These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36833176)

  • 1. Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of
    Di Stazio M; Zanus C; Faletra F; Pesaresi A; Ziccardi I; Morgan A; Girotto G; Costa P; Carrozzi M; d'Adamo AP; Musante L
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833176
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Asif M; Kaygusuz E; Shinawi M; Nickelsen A; Hsieh TC; Wagle P; Budde BS; Hochscherf J; Abdullah U; Höning S; Nienberg C; Lindenblatt D; Noegel AA; Altmüller J; Thiele H; Motameny S; Fleischer N; Segal I; Pais L; Tinschert S; Samra NN; Savatt JM; Rudy NL; De Luca C; ; Paola Fortugno ; White SM; Krawitz P; Hurst ACE; Niefind K; Jose J; Brancati F; Nürnberg P; Hussain MS
    HGG Adv; 2022 Jul; 3(3):100111. PubMed ID: 35571680
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding Phenotype of Poirier-Bienvenu Syndrome: New Evidence from an Italian Multicentrical Cohort of Patients.
    Orsini A; Santangelo A; Bravin F; Bonuccelli A; Peroni D; Battini R; Foiadelli T; Bertini V; Valetto A; Iacomino M; Nigro V; Torella AL; Scala M; Capra V; Vari MS; Fetta A; Di Pisa V; Montanari F; Epifanio R; Bonanni P; Giorda R; Operto F; Pastorino G; Sarigecili E; Sardaroglu E; Okuyaz C; Bozdogan S; Musante L; Faletra F; Zanus C; Ferretti A; Vigevano F; Striano P; Cordelli DM
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing Interruption by Intron Variants in
    Zhang W; Ye F; Chen S; Peng J; Pang N; Yin F
    Front Neurosci; 2022; 16():892768. PubMed ID: 35774559
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive functional, statistical and structural analysis of
    Unni P; Friend J; Weinberg J; Okur V; Hochscherf J; Dominguez I
    Front Mol Biosci; 2022; 9():851547. PubMed ID: 36310603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B.
    Li D; Zhou B; Tian X; Chen X; Wang Y; Hao S; Zhang C; Hui L
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2327. PubMed ID: 38037515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature.
    Chen X; Han Y; Li X; Huang S; Yuan H; Qin Y
    Front Pediatr; 2023; 11():967701. PubMed ID: 37020656
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yang Q; Zhang Q; Yi S; Qin Z; Shen F; Ou S; Luo J; He S
    Front Neurol; 2022; 13():811092. PubMed ID: 35370893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poirier-Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth.
    Selvam P; Jain A; Cheema A; Atwal H; Forghani I; Atwal PS
    Am J Med Genet A; 2021 Feb; 185(2):539-543. PubMed ID: 33166063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining of the electroclinical phenotype in familial and sporadic cases of CSNK2B-related Neurodevelopmental Syndrome.
    Trivisano M; Dominicis A; Stregapede F; Quintavalle C; Micalizzi A; Cappelletti S; Dentici ML; Sinibaldi L; Calabrese C; Terracciano A; Vigevano F; Novelli A; Specchio N
    Epilepsy Behav; 2023 Oct; 147():109436. PubMed ID: 37717460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.
    Nakashima M; Tohyama J; Nakagawa E; Watanabe Y; Siew CG; Kwong CS; Yamoto K; Hiraide T; Fukuda T; Kaname T; Nakabayashi K; Hata K; Ogata T; Saitsu H; Matsumoto N
    J Hum Genet; 2019 Apr; 64(4):313-322. PubMed ID: 30655572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy.
    Poirier K; Hubert L; Viot G; Rio M; Billuart P; Besmond C; Bienvenu T
    Hum Mutat; 2017 Aug; 38(8):932-941. PubMed ID: 28585349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [De novo variant of CSNK2B causes Poirier-Bienvenu neurodevelopmental syndrome: two case report].
    Zhang J; Li Y; Luo H; Shen Y; Yuan M; Yang Z; Gan J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):484-487. PubMed ID: 35598262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two different presentations of de novo variants of CSNK2B: two case reports.
    Wilke MVMB; Oliveira BM; Pereira A; Doriqui MJR; Kok F; Souza CFM
    J Med Case Rep; 2022 Jan; 16(1):4. PubMed ID: 34983633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome-Two Sides of the Same Coin?
    Ballardin D; Cruz-Gamero JM; Bienvenu T; Rebholz H
    Front Mol Biosci; 2022; 9():850559. PubMed ID: 35693553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline de novo variants in CSNK2B in Chinese patients with epilepsy.
    Li J; Gao K; Cai S; Liu Y; Wang Y; Huang S; Zha J; Hu W; Yu S; Yang Z; Xie H; Yan H; Wang J; Wu Y; Jiang Y
    Sci Rep; 2019 Nov; 9(1):17909. PubMed ID: 31784560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and epilepsy spectrum of Poirier-Bienvenu neurodevelopmental syndrome: Description of a new case study and review of the available literature.
    Bonanni P; Baggio M; Duma GM; Negrin S; Danieli A; Giorda R
    Seizure; 2021 Dec; 93():133-139. PubMed ID: 34740143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.
    Ernst ME; Baugh EH; Thomas A; Bier L; Lippa N; Stong N; Mulhern MS; Kushary S; Akman CI; Heinzen EL; Yeh R; Bi W; Hanchard NA; Burrage LC; Leduc MS; Chong JSC; Bend R; Lyons MJ; Lee JA; Suwannarat P; Brilstra E; Simon M; Koopmans M; van Binsbergen E; Groepper D; Fleischer J; Nava C; Keren B; Mignot C; Mathieu S; Mancini GMS; Madan-Khetarpal S; Infante EM; Bluvstein J; Seeley A; Bachman K; Klee EW; Schultz-Rogers LE; Hasadsri L; Barnett S; Ellingson MS; Ferber MJ; Narayanan V; Ramsey K; Rauch A; Joset P; Steindl K; Sheehan T; Poduri A; Vasquez A; Ruivenkamp C; White SM; Pais L; Monaghan KG; Goldstein DB; Sands TT; Aggarwal V
    Epilepsia; 2021 Jul; 62(7):e103-e109. PubMed ID: 34041744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.